1. Short-duration multiple-session subthreshold micropulse yellow laser (577 nm) for chronic central serous chorioretinopathy: results at 3 years
- Author
-
Han Sang Park, San Seong, Daruchi Moon, Si Yeol Kim, Yang Jae Kim, Seungmin Ha, and Oh Woong Kwon
- Subjects
Adult ,Male ,medicine.medical_specialty ,Time Factors ,Visual acuity ,Visual Acuity ,Chronic central serous chorioretinopathy ,Article ,Serous Retinal Detachment ,03 medical and health sciences ,0302 clinical medicine ,Yellow laser ,Ophthalmology ,medicine ,Humans ,Short duration ,Retrospective Studies ,Laser Coagulation ,Retinal pigment epithelium ,Subthreshold conduction ,business.industry ,Subretinal Fluid ,Middle Aged ,Treatment Outcome ,medicine.anatomical_structure ,Central Serous Chorioretinopathy ,Chronic Disease ,030221 ophthalmology & optometry ,Female ,Lasers, Semiconductor ,medicine.symptom ,Subretinal fluid ,business ,030217 neurology & neurosurgery ,Follow-Up Studies - Abstract
OBJECTIVES: To review the 3-year follow-up results of subthreshold micropulse yellow laser (SMYL) delivered by a short-duration multiple-session method for treatment of chronic central serous chorioretinopathy (CSC). METHODS: A total of 27 eyes from 27 patients with chronic CSC available for 3 years of follow-up were enrolled in this retrospective and interventional study. Patients were treated with 577-nm SMYL photocoagulation at a 15% duty cycle over multiple sessions, with low power ranging from 200 to 400 mW that was increased in 100 mW increments according to resolution of subretinal fluid at monthly follow-up. Laser titration was not performed. A treatment duration of 20 ms rather than the conventional duration (100–300 ms) was applied over the area of retinal pigment epithelium leakage and all areas of serous retinal detachment, including the fovea. RESULTS: The mean follow-up period was 3.7 ± 0.8 years (range, 3–6 years). A total of 22 out of 27 eyes (81.5%) including six cases of recurrence during the follow-up period exhibited complete resolution of subretinal detachment at final follow-up, whereas only five eyes (15.5%) had either a partial or null response to SMYL treatment. The baseline best-corrected visual acuity was 0.26 ± 0.24 logarithm of the minimum angle of resolution (logMAR), which was improved to 0.08 ± 0.15 logMAR at 1-year (p = 0.005) and 3-year (p = 0.01) follow-up. The central macular thickness at baseline was 389.6 ± 103.4 μm, which was changed to 197.2 ± 40.0 μm (p
- Published
- 2019
- Full Text
- View/download PDF